Select the Industry/ Sector 👉    All Sectors

Top Healthcare Sector Companies in India by Market Cap

Company
Analysis-Long & Short Term
Industry
Price (EOD)
MarketCap
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹29,451.6
₹62,583 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,531.9
₹31,632 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹419.0
₹6,594 Cr
Pharmaceuticals & Drugs
₹700.1
₹6,346 Cr
Pharmaceuticals & Drugs
₹430.0
₹3,924 Cr
Pharmaceuticals & Drugs
₹311.6
₹3,488 Cr
Pharmaceuticals & Drugs
₹100.0
₹2,568 Cr
Pharmaceuticals & Drugs
₹787.3
₹449 Cr
Pharmaceuticals & Drugs
₹89.5
₹254 Cr
Pharmaceuticals & Drugs
₹34.0
₹166 Cr

Top Healthcare Sector Companies in India by Revenues

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Revenues (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,531.9
₹4,973 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹419.0
₹4,108 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : Average
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹430.0
₹2,477 Cr
Pharmaceuticals & Drugs
₹700.1
₹1,906 Cr
Pharmaceuticals & Drugs
₹311.6
₹707 Cr
Pharmaceuticals & Drugs
₹100.0
₹224 Cr
Pharmaceuticals & Drugs
₹34.0
₹111 Cr
Pharmaceuticals & Drugs
₹29,451.6
₹6,714 Cr
Pharmaceuticals & Drugs
₹787.3
₹316 Cr
Pharmaceuticals & Drugs
₹89.5
₹428 Cr

Top Healthcare Sector Companies in India by Net Profit

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Net Profit (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,531.9
₹974 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹419.0
₹323 Cr
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹700.1
₹242 Cr
Pharmaceuticals & Drugs
₹430.0
₹199 Cr
Pharmaceuticals & Drugs
₹311.6
₹151 Cr
Pharmaceuticals & Drugs
₹100.0
₹144 Cr
Pharmaceuticals & Drugs
₹34.0
₹5 Cr
Pharmaceuticals & Drugs
₹29,451.6
₹1,509 Cr
Pharmaceuticals & Drugs
₹787.3
₹-15 Cr
Pharmaceuticals & Drugs
₹89.5
₹4 Cr

You may also like the below Video Courses